BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26303708)

  • 1. Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids.
    Dreijerink KM; Derks JL; Cataldo I; Scarpa A; Valk GD; Speel EJ
    Front Horm Res; 2015; 44():115-38. PubMed ID: 26303708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of neuroendocrine tumors.
    Öberg K
    Semin Oncol; 2013 Feb; 40(1):37-44. PubMed ID: 23391111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NETs: organ-related epigenetic derangements and potential clinical applications.
    Cives M; Simone V; Rizzo FM; Silvestris F
    Oncotarget; 2016 Aug; 7(35):57414-57429. PubMed ID: 27418145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine tumours: cracking the epigenetic code.
    Karpathakis A; Dibra H; Thirlwell C
    Endocr Relat Cancer; 2013 Jun; 20(3):R65-82. PubMed ID: 23429748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.
    Faivre S; Sablin MP; Dreyer C; Raymond E
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):811-26. PubMed ID: 21095547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroenteropancreatic endocrine tumors.
    Meeker A; Heaphy C
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis CG; Caplin ME
    Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress and application of genetics and epigenetics in pancreatic neuroendocrine numors].
    Ren SQ; Zheng L; Yuan CH
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2801-2805. PubMed ID: 31550805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Starker LF; Carling T
    Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
    Pipinikas CP; Berner AM; Sposito T; Thirlwell C
    Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
    Larsson C
    Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?
    Sun TY; Hendifar A; Padda SK
    Curr Oncol Rep; 2022 Jul; 24(7):819-824. PubMed ID: 35305210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis and targeted therapy of sporadic pancreatic neuroendocrine tumors.
    Capurso G; Archibugi L; Delle Fave G
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):594-601. PubMed ID: 25619712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
    Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
    Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.
    Komori Y; Yada K; Ohta M; Uchida H; Iwashita Y; Fukuzawa K; Kashima K; Yokoyama S; Inomata M; Kitano S
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):288-95. PubMed ID: 24002888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Mafficini A; Scarpa A
    Endocr Rev; 2019 Apr; 40(2):506-536. PubMed ID: 30657883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic neuroendocrine tumors: pathologic and molecular characteristics.
    Shi C; Klimstra DS
    Semin Diagn Pathol; 2014 Nov; 31(6):498-511. PubMed ID: 25441311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dictating genomic destiny: Epigenetic regulation of pancreatic neuroendocrine tumours.
    Gundara JS; Jamal K; Kurzawinski T
    Mol Cell Endocrinol; 2018 Jul; 469():85-91. PubMed ID: 28385665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead.
    Colao A; de Nigris F; Modica R; Napoli C
    Front Endocrinol (Lausanne); 2020; 11():604341. PubMed ID: 33384663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.